MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 531310 | Name: SU 5205
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

SU 5205 is a VEGFR2 inhibitor.

Chemical Structure

SU 5205
SU 5205
CAS#3476-86-6

Theoretical Analysis

MedKoo Cat#: 531310

Name: SU 5205

CAS#: 3476-86-6

Chemical Formula: C15H10FNO

Exact Mass: 239.0746

Molecular Weight: 239.25

Elemental Analysis: C, 75.30; H, 4.21; F, 7.94; N, 5.85; O, 6.69

Price and Availability

Size Price Availability Quantity
50mg USD 250.00 2 Weeks
100mg USD 450.00 2 Weeks
200mg USD 750.00 2 Weeks
500mg USD 1,650.00 2 Weeks
1g USD 2,950.00 2 Weeks
2g USD 5,250.00 2 Weeks
Show More
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
SU 5205; SU-5205; SU5205.
IUPAC/Chemical Name
2-Indolinone, 3-(p-fluorobenzylidene)-
InChi Key
QIERHADIMMFZNE-LCYFTJDESA-N
InChi Code
InChI=1S/C15H10FNO/c16-11-7-5-10(6-8-11)9-13-12-3-1-2-4-14(12)17-15(13)18/h1-9H,(H,17,18)/b13-9-
SMILES Code
O=C1NC2=C(C=CC=C2)/C1=C/C3=CC=C(F)C=C3
Appearance
Yellow solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Product Data
Instruction
View handling instruction
Biological target:
SU 5205 is an inhibitor of VEGFR2 (FLK-1), with an IC50 of 9.6 μM.
In vitro activity:
To be determined
In vivo activity:
To be determined
Solvent mg/mL mM
Solubility
DMSO 250.0 1,044.98
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 239.25 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
To be determined
In vitro protocol:
To be determined
In vivo protocol:
To be determined
1: Tian XF, Huang GM, Zang HL, Cao H. PACE4 regulates apoptosis in human pancreatic cancer Panc 1 cells via the mitochondrial signaling pathway. Mol Med Rep. 2016 Dec;14(6):5205-5210. doi: 10.3892/mmr.2016.5885. PubMed PMID: 27779720. 2: Tanaka S, Kaneko H, Kano H, Matsuno S, Suzuki S, Takai H, Otsuka T, Uejima T, Oikawa Y, Nagashima K, Kirigaya H, Sagara K, Yajima J, Sawada H, Aizawa T, Yamashita T. The predictive value of the borderline ankle-brachial index for long-term clinical outcomes: An observational cohort study. Atherosclerosis. 2016 Jul;250:69-76. doi: 10.1016/j.atherosclerosis.2016.05.014. PubMed PMID: 27182960. 3: Philip F, Blackstone E, Kapadia SR. Impact of statins and beta-blocker therapy on mortality after coronary artery bypass graft surgery. Cardiovasc Diagn Ther. 2015 Feb;5(1):8-16. doi: 10.3978/j.issn.2223-3652.2015.02.01. PubMed PMID: 25774344; PubMed Central PMCID: PMC4329164. 4: Philip F, Becker M, Galla J, Blackstone E, Kapadia SR. Transient post-operative atrial fibrillation predicts short and long term adverse events following CABG. Cardiovasc Diagn Ther. 2014 Oct;4(5):365-72. doi: 10.3978/j.issn.2223-3652.2014.09.02. PubMed PMID: 25414823; PubMed Central PMCID: PMC4221324. 5: Suzuki G, Yamazaki H, Ogo E, Abe T, Eto H, Muraki K, Hattori C, Umeno H, Tanaka N, Tanaka T, Nakamura S, Yoshida K. Predisposing factors for larynx preservation strategies with non-surgical multimodality treatment for locally advanced (T3-4) larynx, hypopharynx and cervical esophageal disease. Anticancer Res. 2014 Sep;34(9):5205-10. PubMed PMID: 25202116. 6: Brunocilla E, Gentile G, Schiavina R, Borghesi M, Franceschelli A, Pultrone CV, Chessa F, Romagnoli D, Ghanem SM, Gacci M, Martorana G, Colombo F. Testis-sparing surgery for the conservative management of small testicular masses: an update. Anticancer Res. 2013 Nov;33(11):5205-10. Review. PubMed PMID: 24222171. 7: Almesbah F, Mandiwanza T, Kaliaperumal C, Caird J, Crimmins D. Routine preoperative blood testing in pediatric neurosurgery. J Neurosurg Pediatr. 2013 Dec;12(6):615-21. doi: 10.3171/2013.8.PEDS13254. PubMed PMID: 24093590. 8: Kooby DA, Gillespie TW, Liu Y, Byrd-Sellers J, Landry J, Bian J, Lipscomb J. Impact of adjuvant radiotherapy on survival after pancreatic cancer resection: an appraisal of data from the national cancer data base. Ann Surg Oncol. 2013 Oct;20(11):3634-42. doi: 10.1245/s10434-013-3047-x. PubMed PMID: 23771249; PubMed Central PMCID: PMC4868076. 9: Liang YL, Yu YC, Liu K, Wang WJ, Ying JB, Wang YF, Cai XJ. Repair of bile duct defect with degradable stent and autologous tissue in a porcine model. World J Gastroenterol. 2012 Oct 7;18(37):5205-10. doi: 10.3748/wjg.v18.i37.5205. PubMed PMID: 23066314; PubMed Central PMCID: PMC3468852. 10: Cosmatos I, Matcho A, Weinstein R, Montgomery MO, Stang P. Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J Am Acad Dermatol. 2013 Mar;68(3):412-9. doi: 10.1016/j.jaad.2012.07.027. PubMed PMID: 22921795. 11: Lin F, Li Y, Cao J, Fan S, Wen J, Zhu G, Du H, Liang Y. Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells. Mol Biol Rep. 2011 Nov;38(8):5205-10. doi: 10.1007/s11033-010-0671-4. PubMed PMID: 21188534. 12: Zorn KC. Editorial comment re: Predictors of early urinary continence after robotic prostatectomy. Can J Urol. 2010 Jun;17(3):5205-6. PubMed PMID: 20566015. 13: van Isterdael CE, Stilma JS, Bezemer PD, Tijmes NT. [Determining factors for deciding whether or not to treat refractive errors and cataract in people with a learning disability]. Ned Tijdschr Geneeskd. 2008 May 3;152(18):1048-51. Dutch. PubMed PMID: 18547027. 14: Poma PA, Barber A. Fallopian tube necrosis after postpartum sterilization. J Natl Med Assoc. 2001 Apr;93(4):149-50. PubMed PMID: 12653402; PubMed Central PMCID: PMC2593986. 15: Erikson J. Fisher given new role in cancer project. Science. 1995 Mar 24;267(5205):1762. PubMed PMID: 7892594. 16: Bereznitskiĭ IaS, Ruban VM, Spivak VP. [Postoperative complications and mortality in peptic ulcer of the duodenum and stomach]. Klin Khir. 1994;(10):41-3. Russian. PubMed PMID: 7602907.